Dr. Brendan D. Curti, MD
Claim this profileProvidence Portland Medical Center
Studies Melanoma
Studies Cancer
14 reported clinical trials
26 drugs studied
Area of expertise
1Melanoma
Stage IV
Stage II
Alkaline Phosphatase
2Cancer
Stage IV
Stage III
Affiliated Hospitals
Clinical Trials Brendan D. Curti, MD is currently running
GB1211 + Pembrolizumab
for Melanoma and Head & Neck Cancer
The purpose of this study is to determine the objective response of GB1211 and pembrolizumab versus pembrolizumab and placebo in patients with advance metastatic melanoma or head and neck squamous cell carcinoma.
Recruiting0 awards Phase 211 criteria
CAN1012 Injections
for Cancer
This trial tests CAN1012, a drug that activates the immune system, in patients with advanced cancer who can't use standard treatments. The drug works by stimulating the immune system to fight cancer cells.
Recruiting1 award Phase 18 criteria
More about Brendan D. Curti, MD
Clinical Trial Related1 year of experience running clinical trials · Led 14 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Brendan D. Curti, MD has experience with
- Nivolumab
- Ipilimumab
- Pembrolizumab
- Placebo
- Carboplatin
- Cisplatin
Breakdown of trials Brendan D. Curti, MD has run
Melanoma
Cancer
Prostate Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Brendan D. Curti, MD specialize in?
Brendan D. Curti, MD focuses on Melanoma and Cancer. In particular, much of their work with Melanoma has involved Stage IV patients, or patients who are Stage II.
Is Brendan D. Curti, MD currently recruiting for clinical trials?
Yes, Brendan D. Curti, MD is currently recruiting for 4 clinical trials in Portland Oregon. If you're interested in participating, you should apply.
Are there any treatments that Brendan D. Curti, MD has studied deeply?
Yes, Brendan D. Curti, MD has studied treatments such as Nivolumab, Ipilimumab, Pembrolizumab.
What is the best way to schedule an appointment with Brendan D. Curti, MD?
Apply for one of the trials that Brendan D. Curti, MD is conducting.
What is the office address of Brendan D. Curti, MD?
The office of Brendan D. Curti, MD is located at: Providence Portland Medical Center, Portland, Oregon 97213 United States. This is the address for their practice at the Providence Portland Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.